AMC prescribes VIVID Brain for stroke-related visual impairments

The digital therapeutic can customise treatment according to each patient’s progress.

South Korea’s Asan Medical Centre (AMC) has begun prescribing VIVID Brain, a digital therapeutic developed for patients with visual impairments caused by stroke.

A 12-week treatment programme involves patients using a virtual reality device and a mobile application. VIVID Brain performs a visual perception evaluation to assess the optimal training location.

In addition, the device is capable of customising treatment by automatically adjusting the difficulty level according to each patient's training progress.

According to AMC, the therapy focuses on improving visual sensitivity through ongoing training in perceptual abilities related to visual stimuli, promoting brain plasticity and reactivating dormant areas around stroke-affected regions.